Last updated on April 24, 2014 at 21:24 EDT

The Leukemia & Lymphoma Society Launches New Co-Pay Assistance Program

January 16, 2007

WHITE PLAINS, N.Y., Jan. 16 /PRNewswire/ — Patients with blood cancers who have difficulty paying for or simply cannot afford their prescription drug co-pays or health insurance premiums can now apply for assistance from The Leukemia & Lymphoma Society.

The new program is available only to patients with myeloma, lymphoma and acute myelogenous leukemia. The Society will provide financial support for patients whose income is at or within 300 percent above the Federal Poverty Level. (Information on the Federal Poverty Level is available at http://aspe.hhs.gov/poverty/.)

“Receiving a diagnosis of a blood cancer is overwhelming and that devastating news can be compounded by an inability to afford the treatments,” said Dwayne Howell, the Society’s president and CEO. “The Society is trying to do what it can to help alleviate this burden for the patients that it serves.”

Requests for assistance will be processed on a first-come, first-served basis. Patients with private insurance, Medicare beneficiaries under Medicare part B and/or Medicare Part D, Medicare Supplementary Health Insurance or Medicare Advantage are eligible if they meet the income requirements.

Patients will need to fill out an application available online at http://www.lls.org/copay or by calling (877) LLS-COPAY. They will also have to provide a diagnosis and disease form, available online, completed and signed by their physician, that confirms a blood cancer diagnosis and lists prescribed medications.

For more information on the program visit http://www.lls.org/copay or call 877-LLS-COPAY.

About The Leukemia & Lymphoma Society

The Leukemia & Lymphoma Society(R), headquartered in White Plains, NY, with 66 chapters in the United States and Canada, is the world’s largest voluntary health organization dedicated to funding blood cancer research and providing education and patient services. The Society’s mission: Cure leukemia, lymphoma, Hodgkin’s disease and myeloma, and improve the quality of life of patients and their families. Since its founding in 1949, the Society has invested more than $483 million in research specifically targeting leukemia, lymphoma and myeloma. Last year alone, the Society made 4.2 million contacts with patients, caregivers and healthcare professionals.

For more information about blood cancer, visit http://www.lls.org/ or call the Society’s Information Resource Center (IRC), a call center staffed by master’s level social workers, nurses and health educators who provide information, support and resources to patients and their families and caregivers. IRC information specialists are available at (800) 955-4572, Monday through Friday, 9 a.m. to 6 p.m. ET.

   Contact: Andrea Greif            914.821.8958            andrea.greif@lls.org  

The Leukemia & Lymphoma Society

CONTACT: Andrea Greif of The Leukemia & Lymphoma Society,+1-914-821-8958, andrea.greif@lls.org

Web site: http://www.lls.org/